1.
Teng Y, Guo R, Sun J, Liu Y. Reactive capillary hemangiomas induced by camrelizumab (SHR-1210), an anti-PD-1 agent. AO [Internet]. 2019 Mar. 4 [cited 2025 Feb. 21];58(3):388-9. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24442